Bin Xu

Bin Xu currently serves as the Lead Engineer in Gene Therapy Process Development at Sarepta Therapeutics, a position held since January 2023. Previously, Bin Xu worked as a Scientist II in Process Development at BlueRock Therapeutics from May 2022 to January 2023 and as an Engineer III in Cell Product Development at Rubius Therapeutics from September 2019 to April 2022. Bin Xu earned a PhD in Biomedical Engineering from the University of Minnesota, where studies were conducted from August 2013 to August 2019, and holds a Master's degree in Bioengineering from Rice University, completed in December 2012.